DAPTOPMYCIN EQUITY


Powder for Solution for infusion
scheduling status
S4
registration number
54/20.1/0841
What DAPTOPMYCIN EQUITY contains
Each vial contains 500 mg daptomycin as a sterile, lyophilised powder.
other ingredients
Sodium hydroxide (to adjust pH).
Therapeutic classification
J01XX09.
© 2026 SAHPRA. ALL RIGHTS RESERVED